Literature DB >> 15243918

Prevalence and determinants of genital infection with papillomavirus, in female and male university students in Busan, South Korea.

Hai-Rim Shin1, Silvia Franceschi, Salvatore Vaccarella, Ju-Won Roh, Young-Hee Ju, Jin-Kyoung Oh, Hyun-Joo Kong, Seo-Hee Rha, Se-Il Jung, Jung-Il Kim, Kap-Yeol Jung, Leen-Jan van Doorn, Wim Quint.   

Abstract

BACKGROUND: Little is known about the prevalence of human papillomavirus (HPV) infection in young adults in Asia.
METHODS: We invited female and male students in Busan, South Korea, to participate in a survey that included, for females, self-collection of vaginal cells and, for males, physician-performed collection of exfoliated genital cells. The prevalences of 25 HPV types were evaluated, by a polymerase chain reaction-based assay, in 672 female students (median age, 19 years) and in 381 male students (median age, 22 years).
RESULTS: HPV DNA was detected more frequently in female students (15.2%) than in male students (8.7%); in both sexes, high-risk HPV types were predominant. Among sexually active students, HPV prevalence was 38.8% in females and 10.6% in males. In female students, currently smoking cigarettes and having multiple lifetime sex partners were the strongest risk factors for HPV infection; in male students, associations between HPV prevalence and sexual habits were similar to those in female students but never attained statistical significance.
CONCLUSIONS: Young women in South Korea start having penetrative sexual intercourse relatively late (median age, 18 years), but, once they begin, HPV prevalence quickly rises to levels comparable with those found in university students in the United States and in northern Europe. The high rate of participation in our study suggests that trials of new vaccines against HPV may be feasible among university students in South Korea.

Entities:  

Mesh:

Year:  2004        PMID: 15243918     DOI: 10.1086/421279

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  65 in total

1.  Race and prevalence of human papillomavirus infection among men residing in Brazil, Mexico and the United States.

Authors:  Gabriel O Akogbe; Abidemi Ajidahun; Bradley Sirak; Gabriella M Anic; Mary R Papenfuss; William J Fulp; Hui-Yi Lin; Martha Abrahamsen; Luisa L Villa; Eduardo Lazcano-Ponce; Manuel Quiterio; Danelle Smith; Matthew B Schabath; Jorge Salmeron; Anna R Giuliano
Journal:  Int J Cancer       Date:  2012-01-11       Impact factor: 7.396

2.  Infectious disease: male circumcision for preventing HPV infection.

Authors:  Ronald H Gray
Journal:  Nat Rev Urol       Date:  2009-06       Impact factor: 14.432

3.  Human papillomavirus prevalence and genotype distribution among HIV-infected women in Korea.

Authors:  Eun Kyoung Park; Heerim Cho; Sun Hee Lee; Seung Geun Lee; Sang Yeup Lee; Ki Hyung Kim; Chang Hun Lee; Joo Seop Chung; Ihm Soo Kwak
Journal:  J Korean Med Sci       Date:  2013-12-26       Impact factor: 2.153

4.  Human papillomavirus infection in men residing in Brazil, Mexico, and the USA.

Authors: 
Journal:  Salud Publica Mex       Date:  2008 Sep-Oct

Review 5.  The impact of smoking on HPV infection and the development of anogenital warts.

Authors:  Reto Kaderli; Beat Schnüriger; Lukas E Brügger
Journal:  Int J Colorectal Dis       Date:  2014-06-17       Impact factor: 2.571

6.  Circumcision and human papillomavirus infection in men: a site-specific comparison.

Authors:  B Y Hernandez; L R Wilkens; X Zhu; K McDuffie; P Thompson; Y B Shvetsov; L Ning; M T Goodman
Journal:  J Infect Dis       Date:  2008-03-15       Impact factor: 5.226

7.  The optimal anatomic sites for sampling heterosexual men for human papillomavirus (HPV) detection: the HPV detection in men study.

Authors:  Anna R Giuliano; Carrie M Nielson; Roberto Flores; Eileen F Dunne; Martha Abrahamsen; Mary R Papenfuss; Lauri E Markowitz; Danelle Smith; Robin B Harris
Journal:  J Infect Dis       Date:  2007-09-17       Impact factor: 5.226

8.  Risk factors for anogenital human papillomavirus infection in men.

Authors:  Carrie M Nielson; Robin B Harris; Eileen F Dunne; Martha Abrahamsen; Mary R Papenfuss; Roberto Flores; Lauri E Markowitz; Anna R Giuliano
Journal:  J Infect Dis       Date:  2007-09-17       Impact factor: 5.226

9.  Vaccination with a human papillomavirus (HPV)-16/18 AS04-adjuvanted cervical cancer vaccine in Korean girls aged 10-14 years.

Authors:  Young-Jae Kim; Kyung-Tai Kim; Jae-Hoon Kim; Soon-Do Cha; Jae Weon Kim; Duk-Soo Bae; Joo-Hyun Nam; Woong-Shick Ahn; Ho-Sun Choi; Timothy Ng; Dan Bi; Jin-Ju OK; Dominique Descamps; Hans L Bock
Journal:  J Korean Med Sci       Date:  2010-07-21       Impact factor: 2.153

Review 10.  HPV vaccine: an overview of immune response, clinical protection, and new approaches for the future.

Authors:  Luciano Mariani; Aldo Venuti
Journal:  J Transl Med       Date:  2010-10-27       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.